Boston Scientific treats 1st patient in Zero AF trial, aims for FDA win for Blazer catheter

January 16, 2013 by MassDevice staff

Medical device giant Boston Scientific treats the 1st patient in a clinical trial of its Blazer open-irrigated temperature ablation catheter, hoping to use the results to win FDA clearance to treat patients with heart rhythm disorders.

Boston Scientific logo

Massachusetts medical device giant Boston Scientific (NYSE:BSX) launched a new study of its Blazer Open-Irrigated Temperature Ablation Catheter, hoping to use the results to win FDA approval.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.